Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0000950170-24-070991

Director sold 818,044 shares at an average $0.96 ($785,027)

From the SEC's structured data for this filing

Trades in this filing

PAKIANATHAN DEEPIKA · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-05 Sale : show line 1 in the form −463,518 $0.96 $444,143 346,615 I
2024-06-05 Sale : show line 2 in the form −4,526 $0.96 $4,337 3,385 I
2024-06-06 Sale : show line 3 in the form −117,307 $0.98 $115,289 229,308 I
2024-06-06 Sale : show line 4 in the form −1,145 $0.98 $1,125 2,240 I
2024-06-07 Sale : show line 5 in the form −229,308 $0.95 $218,003 0 I
2024-06-07 Sale : show line 6 in the form −2,240 $0.95 $2,130 0 I
Open-market sales · 818,044 sh · avg $0.96 · $785,027
Loading xslF345X05/ownership.xml…